Navigation Links
AAOMS develops opioid prescribing recommendations
Date:10/5/2017

ROSEMONT, Ill., Oct. 5, 2017 /PRNewswire-USNewswire/ -- In response to the nationwide opioid epidemic, the American Association of Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen – rather than opioids – to be used as a first-line therapy to manage a patient's acute and post-surgical pain.

Recognizing the value and importance of the doctor-patient relationship, the AAOMS White Paper "Opioid Prescribing: Acute and Postoperative Pain Management" stresses that practitioners should be allowed to make individualized pain management decisions for their patients – including drug types, dosages and treatment durations.

If opioids are considered, AAOMS recommends doctors begin with the lowest possible effective dose for the shortest duration possible. Long-acting or extended-release opioids should be avoided as a starting treatment, the document advises. As an alternative, doctors are reminded that ibuprofen and acetaminophen – taken simultaneously – can rival opioids in their analgesic effect.

"Patient safety is the top priority of the American Association of Oral and Maxillofacial Surgeons," said AAOMS President Douglas W. Fain, DDS, MD, FACS. "Therefore, AAOMS has taken a leadership role in combatting the opioid epidemic afflicting this country. It is crucial for our doctors to responsibly prescribe based on individual patient needs and to use non-opioids when appropriate."

When using opioids to manage acute and post-surgical pain, it is recommended that doctors prescribe them safely and expertly, use the state's prescription-drug monitoring program, and inform patients and their families about opioids' potential risks as well as safe use, storage and disposal. Doctors also should remain aware of the most recent public health trends, including potential alternatives to opioids, the document advises.

The white paper recommendations, published in August, are the work of a Special Committee on Opioid Prescribing appointed by the AAOMS Board of Trustees this spring.

"While oral and maxillofacial surgeons should ultimately make all final prescribing decisions, the recommendations in this AAOMS White Paper are intended to provide direction and serve as a supportive resource," the document states.

Among recommendations:

  • Prescribe non-steroidal anti-inflammatory drugs (NSAIDs, generically known as ibuprofen) as first-line pain-relief therapy, unless they are harmful to the patient. In that case, providers should prescribe acetaminophen.
  • Document dosage levels and times of administration of ibuprofen and acetaminophen taken simultaneously to prevent overdosage.
  • Inform patients not to exceed 3,200 milligrams of ibuprofen per day. In addition, the maximum recommended daily dose of acetaminophen is 3,000 milligrams.
  • Access the state's prescription drug-monitoring program or other resources if patient drug misuse is suspected.
  • Document all instructions for each patient's pain relief and prescriptions.
  • Document reasoning for not following these recommendations or those required by state laws or institutions.
  • Consider using a corticosteroid during surgery to limit swelling and lower post-surgical discomfort after wisdom teeth removal.
  • Consider using a long-acting local anesthetic to postpone the onset and severity of post-surgical pain.

According to a 2017 AAOMS survey of its fellows and members, nearly 50 percent of respondents have decreased the number of narcotics they have prescribed for wisdom teeth extraction cases in the last two years. In addition, nearly 72 percent of respondents said they would refill a narcotic pain prescription only if they see the patient first.

The AAOMS white paper is available online at www.aaoms.org/docs/govt_affairs/advocacy_white_papers/opioid_prescribing.pdf.

For information on managing chronic pain, the white paper refers to the Centers for Disease Control and Prevention's Guideline for Prescribing Opioids for Chronic Pain.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/aaoms-develops-opioid-prescribing-recommendations-300531524.html


'/>"/>
SOURCE American Association of Oral & Maxillofacial Surgeons
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Seegene Develops New Normalization Software Technology for Molecular Diagnosis
2. After A Personal Battle to Walk and Back Surgery One of the Worlds Most Prolific Inventors Develops New Product
3. Azumio Teams Up With Berkeley Test, Develops Nitric Oxide Test Strip Reader In Argus
4. Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer
5. LORATI Successfully Develops Effective Treatment for AIDS
6. Ohio Entrepreneur Develops Technology that Allows Patients Control Over Their Healthcare Records
7. Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products
8. Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions
9. PuraMed BioScience Develops a Cannabis-based Epilepsy Medication
10. ITelagen Develops Templates for Urologists, Enhancing NextGen Healthcare Electronic Health Record Platform
11. Enhance Perioperative & Anesthesia Consulting Develops Indices To Measure Hospital Operating Room Efficiency, Costs, Other Key Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/22/2017)... 2017  As the latest Obamacare repeal effort moves ... (R-LA) and Lindsey Graham (R-SC) medical ... device industry is in an odd place.  The industry ... excise tax on medical device sales passed along with ... patients, increased visits and hospital customers with the funding ...
Breaking Medicine Technology:
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
Breaking Medicine News(10 mins):